Open AccessClinical efficacy of bevacizumab combined with cisplatin in the treatment of malignant pleural effusion and ascites caused by lung cancer: a randomized trial
Author(s) -
Zhi Zhou,
Huiqing Li,
Daoqing Hu,
Lanzhu Xie
Publication year - 2021
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 19
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-21-2623
Subject(s) - medicine , ascites , pleural effusion , bevacizumab , gastroenterology , malignant pleural effusion , vascular endothelial growth factor , lung cancer , depression (economics) , cisplatin , somatization , anxiety , chemotherapy , psychiatry , vegf receptors , macroeconomics , economics
To analyze the clinical effect of bevacizumab combined with cisplatin in the treatment of malignant pleural effusion and ascites.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom